• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆中血管活性肠肽(VIP)的放射免疫测定

Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.

作者信息

Fahrenkrug J, Schaffalitzky de Muckadell O V

出版信息

J Lab Clin Med. 1977 Jun;89(6):1379-88.

PMID:325156
Abstract

A sensitive and specific radioimmunoassay for vasoactive intestinal polypeptide (VIP) has been developed, which can detect 3.3 pmol x L-1 of the peptide in plasma. Antisera to highly purified porcine VIP coupled to albumin were raised in eight rabbits. The final dilution, the avidity, and the specificity of each antiserum were determined. 125I-VIP served as label, and highly purified porcine VIP was used as standard. Separtation of antibody-bound and free VIP was achieved by plasma-coated charcoal. Nonspecific interference withe assay system was excluded by extraction of plasma samples with ethanol. The reliability of the assay was investigated by recovery experiments, by serial dilution of plasma samples with high concentration of endogenous VIP, and by immunosorption. The within-and between assay reproducibility at a concentration of 18.3 pmol x L-1 was 1.6 and 2.3 pmol x L-1 (1 S.D.), respectively. Median fasting concentration of VIP in plasma from 74 normal subjects was 7.3 pmol x L-1 (range: 0-20.0 pmol x L-1).

摘要

已开发出一种用于检测血管活性肠肽(VIP)的灵敏且特异的放射免疫分析法,该方法可检测血浆中3.3 pmol×L-1的该肽。用与白蛋白偶联的高度纯化的猪VIP对8只兔子进行免疫,制备抗血清。测定了每种抗血清的最终稀释度、亲和力和特异性。以125I-VIP作为标记物,高度纯化的猪VIP作为标准品。采用血浆包被活性炭法分离抗体结合型和游离型VIP。通过用乙醇提取血浆样本排除了检测系统的非特异性干扰。通过回收率实验、对高浓度内源性VIP的血浆样本进行系列稀释以及免疫吸附实验研究了该检测方法的可靠性。在浓度为18.3 pmol×L-1时,该检测方法的批内和批间重复性分别为1.6和2.3 pmol×L-1(1个标准差)。74名正常受试者血浆中VIP的空腹浓度中位数为7.3 pmol×L-1(范围:0 - 20.0 pmol×L-1)。

相似文献

1
Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.血浆中血管活性肠肽(VIP)的放射免疫测定
J Lab Clin Med. 1977 Jun;89(6):1379-88.
2
Radioimmunoassay of vasoactive intestinal polypeptide in plasma.血浆中血管活性肠肽的放射免疫测定
Scand J Gastroenterol. 1978;13(7):807-13. doi: 10.3109/00365527809182195.
3
Radioimmunoassay for vasoactive intestinal polypeptide (VIP) in plasma before and during endoscopic examinations.内镜检查前及检查期间血浆中血管活性肠肽(VIP)的放射免疫测定。
Hepatogastroenterology. 1982 Aug;29(4):146-50.
4
Measurement of fasting and postprandial plasma VIP in man.人体空腹和餐后血浆血管活性肠肽的测量。
Gut. 1978 Nov;19(11):1043-8. doi: 10.1136/gut.19.11.1043.
5
Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.患有神经嵴肿瘤儿童体内的血管活性肠肽(VIP)
Acta Paediatr Scand. 1982 Sep;71(5):721-5. doi: 10.1111/j.1651-2227.1982.tb09510.x.
6
Fasting and prolonged exercise increase vasoactive intestinal polypeptide (VIP) in plasma.禁食和长时间运动可增加血浆中的血管活性肠肽(VIP)。
Acta Physiol Scand. 1979 Mar;105(3):374-7. doi: 10.1111/j.1748-1716.1979.tb06353.x.
7
Radioimmunoassay of cholecystokinin in human plasma.人血浆中胆囊收缩素的放射免疫测定
Clin Chim Acta. 1981 Mar 19;111(1):81-9. doi: 10.1016/0009-8981(81)90424-1.
8
Radioimmunoassay of vasoactive intestinal polypeptide.血管活性肠肽的放射免疫测定
Anal Biochem. 1979 Sep 1;97(2):286-97. doi: 10.1016/0003-2697(79)90074-5.
9
Vasoactive intestinal polypeptide (VIP) in cirrhosis: arteriovenous extraction in different vascular beds.肝硬化中的血管活性肠肽(VIP):不同血管床的动静脉提取率
Scand J Gastroenterol. 1980;15(7):787-92. doi: 10.3109/00365528009181531.
10
Effect of bile salts on the plasma concentration of immunoreactive vasoactive intestinal polypeptide in man.胆盐对人体血浆中免疫反应性血管活性肠肽浓度的影响。
Endocrinol Jpn. 1989 Feb;36(1):15-21. doi: 10.1507/endocrj1954.36.15.

引用本文的文献

1
Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study.健康志愿者和偏头痛患者在静脉输注血管活性肠肽2小时期间降钙素基因相关肽的血浆水平:一项探索性研究。
Front Neurol. 2022 Apr 1;13:871176. doi: 10.3389/fneur.2022.871176. eCollection 2022.
2
Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers.测量催产素和加压素:生物测定法、免疫测定法与随机数
J Neuroendocrinol. 2016 Oct;28(10). doi: 10.1111/jne.12413.
3
Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells.
GLUTag、NCI-H716和STC-1细胞中的肽产生与分泌:与天然L细胞的比较。
J Mol Endocrinol. 2016 Apr;56(3):201-11. doi: 10.1530/JME-15-0293. Epub 2016 Jan 27.
4
F-18 labeled vasoactive intestinal peptide analogue in the PET imaging of colon carcinoma in nude mice.F-18标记的血管活性肠肽类似物在裸鼠结肠癌正电子发射断层显像中的应用
Biomed Res Int. 2013;2013:420480. doi: 10.1155/2013/420480. Epub 2013 Dec 26.
5
GLP-2 delays but does not prevent the onset of necrotizing enterocolitis in preterm pigs.GLP-2 可延迟,但不能预防早产仔猪坏死性小肠结肠炎的发生。
J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):623-30. doi: 10.1097/MPG.0b013e318286891e.
6
Circulating levels of vasoactive peptides in patients with acute bacterial meningitis.
Intensive Care Med. 2009 Sep;35(9):1604-8. doi: 10.1007/s00134-009-1515-3. Epub 2009 Jun 10.
7
Gene therapy of Cav1.2 channel with VIP and VIP receptor agonists and antagonists: a novel approach to designing promotility and antimotility agents.采用血管活性肠肽及其受体激动剂和拮抗剂对Cav1.2通道进行基因治疗:设计促动力和抗动力药物的新方法。
Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G187-G196. doi: 10.1152/ajpgi.00047.2008. Epub 2008 May 8.
8
Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors.速激肽通过NK-1受体刺激猪回肠释放肽类激素(胰高血糖素样肽-1)、旁分泌物质(生长抑素)和神经递质(血管活性肠肽)。
Dig Dis Sci. 1999 Jul;44(7):1273-81. doi: 10.1023/a:1026610626068.
9
Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.垂体腺苷酸环化酶激活肽在猫和人类下食管括约肌中的分布及作用
Br J Pharmacol. 1995 Dec;116(7):2873-80. doi: 10.1111/j.1476-5381.1995.tb15939.x.
10
Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.人海绵体中的垂体腺苷酸环化酶激活多肽、海洛肽和血管活性肠肽。
Br J Pharmacol. 1995 Oct;116(4):2258-66. doi: 10.1111/j.1476-5381.1995.tb15062.x.